Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Doublesex- and mab-3-related transcription factor C1 (DMRTC1) is a member of the DMRT (doublesex and mab-3 related transcription factor) family and is associated with the regulation of DNA-templated transcription[5][6][8]. Unlike other members, DMRTC1 does not possess the canonical DM DNA-binding domain characteristic of the family[8]. The gene is located on chromosome X and encodes a protein believed to act in the nucleus, most likely in chromatin, in the regulation of transcription[5][7][8]. There are currently no known therapeutic drugs, biomarker applications or well-defined disease associations reported for DMRTC1.
None known (no drugs identified as targeting this factor)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Doublesex- and mab-3-related transcription factor C1 (DMRTC1).